glp-1 and eating disorders #504: Adult in the Era GLP-1 obesity drugs and eating
Description
Ultimately, these actions are left up to shared decision-making
However, researchers soon realised its potential therapeutic use in humans as an anticoagulant
We are human beings who are going through one of the hardest things we will ever go through, she says
The mechanism has not been established
The dedicated cardiovascular outcomes trial (TRIUMPH-Outcomes), enrolling around 10,000 participants with established cardiovascular disease, chronic kidney disease, or high CV risk, is not expected to report until 2027 at the earliest [11]
